Several of Roche’s devices used to check blood glucose, test anticoagulation or monitor heartbeat irregularities have vulnerabilities that could be exploited by a hacker. The report warns about five products, including the Accu-Chek Inform II, CoaguChek Pro II, CoaguChek XS Plus, CoaguChek XS Pro and the cobas h 232 POC system.
Roche has scheduled fixes for the devices and expects the updated products to be released later this month. The company recommend restricting network and physical access to the devices and monitoring the system for suspicious activity.
More articles on supply chain:
Amazon to sell exclusive brand of consumer medical devices
The 1st flu treatment in decades, a diagnostic test for menopause & more: 5 latest FDA approvals
Senate Democrats question if FDA’s digital health pre-certification will ‘compromise public safety’
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
